Phase 1, Placebo-Controlled, Double-Blind, Safety Study of HBV-001 D1 in Healthy Adults.
Phase of Trial: Phase I
Latest Information Update: 03 Feb 2011
At a glance
- Drugs Aluminium hydroxide; Dengue subunit vaccine
- Indications Dengue
- Focus Adverse reactions
- Sponsors Hawaii Biotech
- 03 Feb 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 03 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2010 Preliminary results are expected in the first quarter of 2010, and results are expected by the fourth quarter of 2010, according to a Hawaii Biotech media release.